Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney

NCT00035555 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft Rejection
Kidney Transplantation
Renal Transplantation

Interventions

DRUG: Belatacept
DRUG: Cyclosporine
DRUG: Mycophenolate mofetil (MMF)
DRUG: Corticosteroids

Sponsor

Bristol-Myers Squibb